Transcenta

Transcenta is a pharmaceutical company that researches, develops and commercializes antibody therapeutics for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 201-500

Detailed Transcenta Information

Geographic Data

Transcenta headquarters map

Address: 218 Xinghu Street

City: Suzhou

State: shanghai municipality

Zip: 200000

Country: CN

Financial Info

Stage:

series b

Raised Last:

$100M

Raised Total:

$100M

Metrics

4,301,664Website Global Rank

2,432Website Monthly Traffic

Twitter Followers

Description

Transcenta is a pharmaceutical company that researches, develops and commercializes antibody therapeutics for the treatment of cancer.

Contact Phone:

Contact Email:

Transcenta went public on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

Ticker Symbol:
06628

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2019 Venture Round 6 - Teng Yue Partners
Temasek Holdings
Taikang Life Insurance
Sequoia Capital China
Lilly Asia Ventures
ARCH Venture Partners
Teng Yue Partners
Temasek Holdings
Taikang Life Insurance
Sequoia Capital China
Lilly Asia Ventures
ARCH Venture Partners
12/2020 Venture Round $105M China Structural Reform Fund
Country Garden Venture Capital
Qatar Investment Authority
CCT China Merchants Fund
Lilly Asia Ventures
Sequoia Capital China
1/2020 Series B $0 Temasek Holdings
Teng Yue Partners
Hillhouse Capital Group
China Merchants Capital
Epiphron Capital
Fortune Venture Capital
Sequoia Capital China
Lilly Asia Ventures
China Equity
Yipu Capital
ARCH Venture Partners
CR-CP Life Science Fund
Fortune Venture Capital
Temasek Holdings
Teng Yue Partners
Hillhouse Capital Group
China Merchants Capital
Epiphron Capital
Fortune Venture Capital
Sequoia Capital China
Lilly Asia Ventures
China Equity
Yipu Capital
ARCH Venture Partners
CR-CP Life Science Fund
Fortune Venture Capital
7/2019 Series A $137M
1/2020 Series B 12 $100M Fortune Capital
Epiphron Capital
China Merchants Group Merger Fund
ChinaEquity Group
Lilly Asia Ventures
Temasek Holdings
Hillhouse Capital
Sequoia Capital China
ARCH Venture Partners
Temasek Holdings
Teng Yue Partners
Hillhouse Capital Group
China Merchants Capital
Epiphron Capital
Fortune Venture Capital
Sequoia Capital China
Lilly Asia Ventures
China Equity
Yipu Capital
ARCH Venture Partners
CR-CP Life Science Fund
Fortune Venture Capital
1/2019 Venture Round 6 -
Announced Date Name Price
1/2019 Hangzhou Just Biotherapeutics (Just China)
1/2019 MabSpace Biosciences

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research